IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Non-Current Deferred Tax Liability of -$29897.4 in Q1 2026, down 111.74% quarter-over-quarter from $254565.6 in Q4 2025, and down 7.25% on a YoY basis from -$32234.1 in Q1 2025.
IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
IM Cannabis' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at -$29897.4 for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 7.25% year-over-year to -$29897.4; the TTM figure through Mar 2026 stood at -$29897.4 (down 7.25% YoY), while the FY2025 annual figure was $254565.6, down 28.43% from the prior year.
- Non-Current Deferred Tax Liability was -$29897.4 for Q1 2026 at IM Cannabis, down from $254565.6 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.1 million in Q2 2022 to a low of -$427895.7 in Q1 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $407379.1 across 5 years, with a median of -$27876.7 in 2025.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability plunged 356.67% in 2022, then jumped 496.69% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $981288.3 in 2022, then fell by 27.92% to $707357.7 in 2023, then plunged by 50.72% to $348618.5 in 2024, then declined by 26.98% to $254565.6 in 2025, then slumped by 111.74% to -$29897.4 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at -$29897.4 (Q1 2026), $254565.6 (Q4 2025), and $290654.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,897.43 |
| Mar 31, 2026 | -29,897.43 |
| Dec 31, 2025 | 254,565.63 |
| Dec 31, 2025 | 254,565.63 |
| Sep 30, 2025 | 290,654.00 |
| Sep 30, 2025 | 290,654.00 |
| Jun 30, 2025 | 310,336.37 |
| Jun 30, 2025 | 310,336.37 |
| Mar 31, 2025 | -27,876.66 |
| Mar 31, 2025 | -27,876.66 |
| Dec 31, 2024 | 348,618.53 |
| Dec 31, 2024 | 348,618.53 |
| Sep 30, 2024 | -101,161.37 |
| Sep 30, 2024 | -101,161.37 |
| Jun 30, 2024 | -78,232.04 |
| Jun 30, 2024 | -78,232.04 |
| Mar 31, 2024 | -51,205.81 |
| Mar 31, 2024 | -51,205.81 |
| Dec 31, 2023 | 707,357.71 |
| Dec 31, 2023 | 707,357.71 |